Carvedilol for Prevention of Esophageal Varices Progression
Condition(s):Cirrhosis, Liver; Portal HypertensionLast Updated:December 1, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Cirrhosis, Liver; Portal HypertensionLast Updated:December 1, 2022Active, not recruiting
Condition(s):Portal HypertensionLast Updated:March 14, 2023Not yet recruiting
Condition(s):Clinically Significant Portal HypertensionLast Updated:August 29, 2023Completed
Condition(s):Cardiotoxicity; Risk Factor, Cardiovascular; Toxicity Due to Chemotherapy; Breast Cancer; Cardiomyopathies; Heart FailureLast Updated:October 17, 2022Active, not recruiting
Condition(s):Glioblastoma Multiforme; GlioblastomaLast Updated:September 24, 2021Terminated
Condition(s):Glioblastoma; Glioblastoma MultiformeLast Updated:April 12, 2021Withdrawn
Condition(s):Heart Failure With Preserved Ejection Fraction; Beta Blocker; Myocardial StrainLast Updated:October 20, 2022Recruiting
Condition(s):Ventricular Premature Complexes; Outflow Tract; CarvedilolLast Updated:July 18, 2018Unknown status
Condition(s):Liver Cirrhosis; Portal HypertensionLast Updated:August 25, 2021Recruiting
Condition(s):Chronic Heart FailureLast Updated:August 16, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.